PIK3CA and myeloid sarcoma: The dysregulation of PI3K signalling in microglia, astrocytes, oligodendrocytes, and neurons can drive chronic neuroinflammation and contribute to neurodegenerative disease pathology, including AD, PD, MS, and ALS.